| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459492 | Radiotherapy and Oncology | 2016 | 7 Pages |
Abstract
TCP is robust to dosimetric uncertainties when dose prescription is in the more flat region of the dose-response curve at doses >75Â Gy. For OARs, improved clinical outcome is expected by reduction of uncertainties via sophisticated dose delivery and treatment verification.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nicole Nesvacil, Kari Tanderup, Jacob C. Lindegaard, Richard Pötter, Christian Kirisits,